Guizhou Xinbang Pharmaceutical Co.,Ltd.’s Net Profit Dropped 28.2% in 2022

Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 268.4 million yuan in 2022, down 28.2% year-on-year.

Meanwhile, the company posted 6.4 billion yuan in revenue, down 1.9% year-on-year.

At the end of the reporting period, it had 9.8 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 27.9%.